NASDAQ:NXGN
NextGen Healthcare
- Stock
Last Close
23.91
08/11 21:00
Market Cap
1.61B
Beta: 1.04
Volume Today
3.12M
Avg: 342.09K
PE Ratio
−258.41
PFCF: −37.06
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 490.23M - | 492.48M 0.46% | 509.62M 3.48% | 531.02M 4.20% | 529.17M 0.35% | 540.24M 2.09% | 556.82M 3.07% | 596.35M 7.10% | 653.17M 9.53% | |
cost of revenue | 223.16M - | 225.62M 1.10% | 223.13M 1.10% | 241.53M 8.25% | 246.70M 2.14% | 267.44M 8.41% | 275.42M 2.99% | 295.40M 7.25% | 342.01M 15.78% | |
gross profit | 267.06M - | 266.86M 0.07% | 286.49M 7.36% | 289.48M 1.05% | 282.48M 2.42% | 272.80M 3.43% | 281.40M 3.15% | 300.95M 6.95% | 311.16M 3.39% | |
selling and marketing expenses | ||||||||||
general and administrative expenses | 158.17M - | 156.23M 1.23% | 163.62M 4.73% | |||||||
selling general and administrative expenses | 158.17M - | 156.23M 1.23% | 163.62M 4.73% | 193.23M 18.09% | 164.88M 14.67% | 165.17M 0.18% | 180.53M 9.30% | 209.66M 16.14% | 223.42M 6.56% | |
research and development expenses | 69.24M - | 65.66M 5.17% | 78.34M 19.31% | 81.26M 3.72% | 80.99M 0.33% | 83.30M 2.84% | 75.50M 9.36% | 76.66M 1.53% | 82.30M 7.36% | |
other expenses | -62K - | -166K 167.74% | -262K 57.83% | 7.81M 3,080.92% | 4.34M 44.38% | 4.14M 4.63% | 4.45M 7.39% | 3.52M 20.77% | 3.67M 3.97% | |
cost and expenses | 454.27M - | 452.88M 0.31% | 475.53M 5.00% | 523.83M 10.16% | 496.91M 5.14% | 520.05M 4.66% | 535.90M 3.05% | 585.25M 9.21% | 651.40M 11.30% | |
operating expenses | 231.10M - | 227.26M 1.66% | 252.40M 11.06% | 282.30M 11.84% | 250.22M 11.36% | 252.61M 0.96% | 260.48M 3.11% | 289.84M 11.27% | 309.39M 6.74% | |
interest expense | -230K - | 1.30M 666.96% | 3.16M 142.02% | 3.32M 5.29% | 2.81M 15.32% | 1.96M 30.53% | 3.52M 79.85% | 1.50M 57.37% | 6.30M 320.15% | |
ebitda | 39.65M - | 45.23M 14.07% | 74.28M 64.22% | 15.09M 79.68% | 37.09M 145.75% | 25.43M 31.42% | 70.11M 175.65% | 53.45M 23.75% | 52.93M 0.98% | |
operating income | 35.96M - | 7.36M 79.52% | 27.01M 266.92% | 7.28M 73.05% | 31.62M 334.27% | 21.29M 32.67% | 20.89M 1.87% | 11.14M 46.68% | 16.24M 45.76% | |
depreciation and amortization | 3.69M - | 5.37M 45.33% | 40.43M 653.38% | 7.81M 80.68% | 5.47M 30% | 4.14M 24.22% | 49.21M 1,087.88% | 42.31M 14.02% | 36.69M 13.28% | |
total other income expenses net | -62K - | -32.40M 52,164.52% | -7.34M 77.35% | -7.69M 4.78% | -2.33M 69.69% | -17.03M 630.63% | -11.62M 31.79% | -5.94M 48.83% | -11.93M 100.77% | |
income before tax | 35.66M - | 6.32M 82.28% | 23.61M 273.56% | -410K 101.74% | 29.29M 7,243.41% | 4.26M 85.46% | 9.28M 117.77% | 5.20M 43.98% | 4.30M 17.17% | |
income tax expense | 8.33M - | 663K 92.04% | 5.37M 709.65% | -2.83M 152.72% | 4.79M 269.40% | -3.24M 167.56% | -240K 92.59% | 3.58M 1,590.83% | 6.96M 94.47% | |
net income | 27.33M - | 5.66M 79.30% | 18.24M 222.45% | 2.42M 86.73% | 24.49M 912.15% | 7.50M 69.39% | 9.52M 26.90% | 1.62M 83.00% | -2.65M 264.03% | |
weighted average shs out | 60.26M - | 60.63M 0.62% | 61.82M 1.95% | 63.44M 2.62% | 64.42M 1.55% | 65.47M 1.64% | 66.74M 1.93% | 67.37M 0.95% | 67.00M 0.54% | |
weighted average shs out dil | 60.85M - | 61.23M 0.63% | 62.01M 1.27% | 63.44M 2.31% | 64.60M 1.83% | 65.61M 1.57% | 66.89M 1.94% | 67.79M 1.35% | 67.00M 1.16% | |
eps | 0.45 - | 0.09 80% | 0.30 233.33% | 0.04 86.67% | 0.38 850% | 0.11 71.05% | 0.14 27.27% | 0.02 85.71% | -0.04 298% | |
epsdiluted | 0.45 - | 0.09 80% | 0.29 222.22% | 0.04 86.21% | 0.38 850% | 0.11 71.05% | 0.14 27.27% | 0.02 85.71% | -0.04 298% |
All numbers in USD (except ratios and percentages)